Anders Wall

Inhibitory neurotransmission in frontostriatal circuitry: implications for psychomotor and vegetative symptoms in depressive episodes

Steinholtz, Linda; Persson, Jonas; Thörnblom, Elin; Wall, Anders et al.

Part of BMC Psychiatry, 2026

DOI for Inhibitory neurotransmission in frontostriatal circuitry: implications for psychomotor and vegetative symptoms in depressive episodes
Download full text (pdf) of Inhibitory neurotransmission in frontostriatal circuitry: implications for psychomotor and vegetative symptoms in depressive episodes

Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human

Appel, Lieuwe; Risinger, Robert; Wall, Anders; Murck, Harald et al.

Part of Psychopharmacology, p. 565-580, 2026

Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer's disease mutations

Luckett, Emma S.; Zapater-Fajari, Mariola; Almkvist, Ove; Johansson, Charlotte et al.

Part of Translational Psychiatry, 2026

Alterations in gamma-aminobutyric acid and glutamate neurotransmission linked to intermittent theta-burst stimulation in depression: a sham-controlled study

Steinholtz, Linda; Bodén, Robert; Wall, Anders; Lubberink, Mark et al.

Part of Translational Psychiatry, 2025

Repeated positron emission tomography tracing neutrophil elastase in a porcine intensive-care sepsis model

Wilske, Frida; Eriksson, Olof; Amini, Rose-Marie; Estrada, Sergio et al.

Part of Intensive Care Medicine Experimental, 2025

Radiation dosimetry of para-chloro-2-[¹⁸F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging

Silins, Isabella; Moreno, Adrian; Wall, Anders; Aigbirhio, Franklin et al.

Part of EJNMMI Research, 2024

GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study.

Steinholtz, Linda; Thörnblom, Elin; Bodén, Robert; Wall, Anders et al.

Part of Neuropsychobiology, p. 17-27, 2024

First-in-human evaluation of [¹⁸F]CETO: a novel tracer for adrenocortical tumours

Silins, Isabella; Sundin, Anders; Lubberink, Mark; O'Sullivan, Lleah et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 398-409, 2023

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study

Wechalekar, Ashutosh; Antoni, Gunnar; Al Azzam, Wasfi; Bergstrom, Mats et al.

Part of BMC Cardiovascular Disorders, 2022

E-Cigarette Aerosol Deposition and Disposition of [C-11]Nicotine Using Positron Emission Tomography: A Comparison of Nicotine Uptake in Lungs and Brain Using Two Different Nicotine Formulations

Wall, Anders; Roslin, Sara; Borg, Beatrice; McDermott, Simon et al.

Part of Pharmaceuticals, 2022

Refined Analysis of Chronic White Matter Changes after Traumatic Brain Injury and Repeated Sports-Related Concussions: Of Use in Targeted Rehabilitative Approaches?

Latini, Francesco; Fahlström, Markus; Vedung, Fredrik; Stensson, Staffan et al.

Part of Journal of Clinical Medicine, 2022

Chronic cerebral blood flow alterations in traumatic brain injury and sports-related concussions

Vedung, Fredrik; Fahlström, Markus; Wall, Anders; Antoni, Gunnar et al.

Part of Brain Injury, p. 948-960, 2022

Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients – A PET/MR study

Marklund, Niklas; Vedung, Fredrik; Lubberink, Mark; Tegner, Yelverton et al.

Part of NeuroImage, 2021

[F-18]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer's disease

Chiotis, Konstantinos; Savitcheva, Irina; Poulakis, Konstantinos; Saint-Aubert, Laure et al.

Part of Molecular Psychiatry, p. 5875-5887, 2021

Inhibitory and excitatory neurotransmitter systems in depressed and healthy: A positron emission tomography and magnetic resonance spectroscopy study

Persson, Jonas; Wall, Anders; Weis, Jan; Gingnell, Malin et al.

Part of Psychiatry Research, 2021

Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study

Persson, Jonas; Szalisznyo, Krisztina; Antoni, Gunnar; Wall, Anders et al.

Part of European Archives of Psychiatry and Clinical Neuroscience, p. 451-459, 2020

Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease

Vilaplana, Eduard; Rodriguez-Vieitez, Elena; Ferreira, Daniel; Montal, Victor et al.

Part of Neurology, 2020

Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [¹⁸F]THK5317 PET

Jonasson, My; Wall, Anders; Chiotis, Konstantinos; Leuzy, Antoine et al.

Part of NeuroImage, 2019

Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset

Altomare, Daniele; Ferrari, Clarissa; Caroli, Anna; Galluzzi, Samantha et al.

Part of Journal of Neurology, p. 2535-2545, 2019

DOI for Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia

Chiotis, K; Saint-Aubert, L; Rodriguez-Vieitez, E; Leuzy, A et al.

Part of Molecular Psychiatry, p. 1666-1673, 2018

Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.

Leuzy, Antoine; Rodriguez-Vieitez, Elena; Saint-Aubert, Laure; Chiotis, Konstantinos et al.

Part of Alzheimer's & Dementia, p. 652-663, 2018

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

Thordardottir, Steinunn; Rodriguez-Vieitez, Elena; Almkvist, Ove; Ferreira, Daniel et al.

Part of Alzheimer's Research & Therapy, 2018

Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study

Bodén, Robert; Persson, Jonas; Wall, Anders; Lubberink, Mark et al.

Part of Translational Psychiatry, 2017

Persistent Decrease Of Cerebral Blood Flow In Traumatic Brain Injury And Sports-Related Concussion

Vedung, Fredrik; Antoni, Gunnar; Wall, Anders; Fahlström, Markus et al.

Part of Journal of Neurotrauma, 2017

DOI for Persistent Decrease Of Cerebral Blood Flow In Traumatic Brain Injury And Sports-Related Concussion

Comparability of [F-18]THK5317 and [C-11]PIB blood flow proxy images with [F-18]FDG positron emission tomography in Alzheimer's disease

Rodriguez-Vieitez, Elena; Leuzy, Antoine; Chiotis, Konstantinos; Saint-Aubert, Laure et al.

Part of Journal of Cerebral Blood Flow and Metabolism, p. 740-749, 2017

A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting

Iaccarino, Leonardo; Chiotis, Konstantinos; Alongi, Pierpaolo; Almkvist, Ove et al.

Part of Journal of Alzheimer's Disease, p. 603-614, 2017

DOI for A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting

Striatal Phosphodiesterase 10A and Medial Prefrontal Cortical Thickness in Patients with Schizophrenia: A PET and MRI Study

Bodén, Robert; Persson, Jonas; Wall, Anders; Lubberink, Mark et al.

Part of Biological Psychiatry, 2017

DOI for Striatal Phosphodiesterase 10A and Medial Prefrontal Cortical Thickness in Patients with Schizophrenia: A PET and MRI Study

Tracer kinetic analysis of [18f](s)-thk5117 as a pet tracer for tau pathology

Lubberink, Mark; Jonasson, My; Wall, Anders; Chiotis, K. et al.

Part of Journal of Cerebral Blood Flow and Metabolism, p. 16-17, 2016

Women with Premenstrual Dysphoria Lack the Seemingly Normal Premenstrual Right-Sided Relative Dominance of 5-HTP-Derived Serotonergic Activity in the Dorsolateral Prefrontal Cortices - A Possible Cause of Disabling Mood Symptoms

Eriksson, Olle; Wall, Anders; Olsson, Ulf; Marteinsdottir, Ina et al.

Part of PLOS ONE, 2016

The clinical safety, biodistribution and internal radiation dosimetry of [F-18]AH113804 in healthy adult volunteers

Somer, E. J.; Owenius, Rikard; Wall, Anders; Antoni, Gunnar et al.

Part of EJNMMI Research, 2016

Regional tau deposition measured by [F-18]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease

Saint-Aubert, Laure; Almkvist, Ove; Chiotis, Konstantinos; Almeida, Rita et al.

Part of Alzheimer's Research & Therapy, 2016

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device

Eyjolfsdottir, Helga; Eriksdotter, Maria; Linderoth, Bengt; Lind, Goran et al.

Part of Alzheimer's Research & Therapy, 2016

Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology.

Jonasson, My; Wall, Anders; Chiotis, Konstantinos; Saint-Aubert, Laure et al.

Part of Journal of Nuclear Medicine, p. 574-581, 2016

DOI for Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology.

Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm

Chiotis, Konstantinos; Saint-Aubert, Laure; Savitcheva, Irina; Jelic, Vesna et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1686-1699, 2016

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

Rodriguez-Vieitez, Elena; Saint-Aubert, Laure; Carter, Stephen F.; Almkvist, Ove et al.

Part of Brain, p. 922-936, 2016

Supervised Cluster Analysis for Automatic Extraction of Reference Region in Dynamic [F-18]THK5317 PET

Jonasson, My; Wall, Anders; Chiotis, K.; Heurling, Kerstin et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Striatal Phosphodiesterase 10A and Thinning of the medial Prefrontal Cortex in Schizophrenia - a PET and MRI study

Bodén, Robert; Persson, Jonas; Wall, Anders; Lubberink, Mark et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016

Comparison of Early-Phase C-11-Deuterium-L-Deprenyl and C-11-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease

Rodriguez-Vieitez, Elena; Carter, Stephen F.; Chiotis, Konstantinos; Saint-Aubert, Laure et al.

Part of Journal of Nuclear Medicine, p. 1071-1077, 2016

DOI for Comparison of Early-Phase C-11-Deuterium-L-Deprenyl and C-11-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease

Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics

Prestia, Annapaola; Caroli, Anna; Wade, Sara K.; van der Flier, Wiesjie M. et al.

Part of Alzheimer's & Dementia, p. 1191-1201, 2015

DOI for Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease

Karami, Azadeh; Eyjolfsdottir, Helga; Vijayaraghavan, Swetha; Lind, Goran et al.

Part of Alzheimer's & Dementia, p. 1316-1328, 2015

DOI for Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography

Scholl, Michael; Carter, Stephen F.; Westman, Eric; Rodriguez-Vieitez, Elena et al.

Part of Scientific Reports, 2015

Concordance and Diagnostic Accuracy of [C-11]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease

Leuzy, Antoine; Carter, Stephen F.; Chiotis, Konstantinos; Almkvist, Ove et al.

Part of Journal of Alzheimer's Disease, p. 1077-1088, 2015

DOI for Concordance and Diagnostic Accuracy of [C-11]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment

Nordberg, Agneta; Kadir, Ahmadul; Andreasen, Niels; Almkvist, Ove et al.

Part of Journal of Alzheimer's Disease, p. 691-704, 2015

DOI for Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment

Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression

Caroli, Anna; Prestia, Annapaola; Galluzzi, Samantha; Ferrari, Clarissa et al.

Part of Neurology, p. 508-515, 2015

DOI for Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression

Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition

Farid, Karim; Carter, Stephen F; Rodriguez-Vieitez, Elena; Almkvist, Ove et al.

Part of Journal of Alzheimer's Disease, p. 661-667, 2015

DOI for Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition

Mild cognitive impairment with suspected non AD pathology (SNAP): prediction of progression to dementia

Caroli, A.; Prestia, A.; Galluzzi, S.; Ferrari, C. et al.

Part of European Journal of Neurology, p. 19-19, 2014

Discovery and Development of C-11-Lu AE92686 as a Radioligand for PET Imaging of Phosphodiesterase10A in the Brain

Kehler, Jan; Kilburn, John Paul; Estrada, Sergio; Christensen, Soren Rahn et al.

Part of Journal of Nuclear Medicine, p. 1513-1518, 2014

DOI for Discovery and Development of C-11-Lu AE92686 as a Radioligand for PET Imaging of Phosphodiesterase10A in the Brain

Tracer kinetic analysis of C-11-LuAE92686, a novel PET ligand for imaging of phosphodiesterase 10A

Lubberink, Mark; Wall, Anders; Bruce, S.; Estrada, Sergio et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014

Mild cognitive impairment with suspected non AD pathology (SNAP): prediction of progression to dementia

Caroli, A.; Prestia, A.; Galluzzi, S.; Ferrari, C. et al.

Part of Journal of Neurology, 2014

Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography

Degerman Gunnarsson, Malin; Lindau, M; Santillo, A F; Wall, Anders et al.

Part of Dementia and Geriatric Cognitive Disorders Extra, p. 472-481, 2013

DOI for Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography

Combination of F-18-FDG PET and Cerebrospinal Fluid Biomarkers as a Better Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment Patients

Choo, Il Han; Ni, Ruiqing; Scholl, Michael; Wall, Anders et al.

Part of Journal of Alzheimer's Disease, p. 929-939, 2013

DOI for Combination of F-18-FDG PET and Cerebrospinal Fluid Biomarkers as a Better Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment Patients

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

Prestia, Annapaola; Caroli, Anna; van der Flier, Wiesje M.; Ossenkoppele, Rik et al.

Part of Neurology, p. 1048-1056, 2013

DOI for Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

The clinical safety, biodistribution and internal radiation dosimetry of [F-18]fluciclovine in healthy adult volunteers

McParland, Brian J.; Wall, Anders; Johansson, Silvia; Sörensen, Jens

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1256-1264, 2013

DOI for The clinical safety, biodistribution and internal radiation dosimetry of [F-18]fluciclovine in healthy adult volunteers

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

Schöll, Michael; Wall, Anders; Thordardottir, Steinunn; Ferreira, Daniel et al.

Part of Neurology, p. 229-236, 2012

DOI for Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

Kadir, Ahmadul; Almkvist, Ove; Forsberg, Anton; Wall, Anders et al.

Part of Neurobiology of Aging, p. 1980-19800000000000000, 2012

DOI for Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by (11)C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining (11)C-Pittsburgh Compound B and (18)F-FDG

Carter, Stephen F.; Scholl, Michael; Almkvist, Ove; Wall, Anders et al.

Part of Journal of Nuclear Medicine, p. 37-46, 2012

DOI for Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by (11)C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining (11)C-Pittsburgh Compound B and (18)F-FDG

Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer's Disease

Eriksdotter-Jönhagen, Maria; Linderoth, Bengt; Lind, Goran; Aladellie, Layth et al.

Part of Dementia and Geriatric Cognitive Disorders, p. 18-28, 2012

DOI for Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer's Disease

Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation

Schöll, Michael; Almkvist, Ove; Axelman, Karin; Stefanova, Elka et al.

Part of Neurobiology of Aging, p. 1388-1399, 2011

DOI for Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation

Time Course of Glucose Metabolism in Relation to Cognitive Performance and Postmortem Neuropathology in Met146Val PSEN1 Mutation Carriers

Schöll, Michael; Almkvist, Ove; Bogdanovic, Nenad; Wall, Anders et al.

Part of Journal of Alzheimer's Disease, p. 495-506, 2011

DOI for Time Course of Glucose Metabolism in Relation to Cognitive Performance and Postmortem Neuropathology in Met146Val PSEN1 Mutation Carriers

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Degerman Gunnarsson, Malin; Lindau, Maria; Wall, Anders; Blennow, K et al.

Part of Dementia and Geriatric Cognitive Disorders, p. 204-212, 2010

DOI for Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Small-molecule biomarkers for clinical PET imaging of apoptosis.

Reshef, Ayelet; Shirvan, Anat; Akselrod-Ballin, Ayelet; Wall, Anders et al.

Part of Journal of Nuclear Medicine, p. 837-40, 2010

DOI for Small-molecule biomarkers for clinical PET imaging of apoptosis.

High PIB Retention in Alzheimer's Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters

Forsberg, A; Almkvist, O; Engler, Henry; Wall, Anders et al.

Part of Current Alzheimer Research, p. 56-66, 2010

DOI for High PIB Retention in Alzheimer's Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters

An automated method for delineating a reference region using masked volumewise principal-component analysis in 11C-PIB PET

Razifar, Pasha; Engler, Henry; Ringheim, Anna; Estrada, Sergio et al.

Part of Journal of Nuclear Medicine Technology, p. 38-44, 2009

DOI for An automated method for delineating a reference region using masked volumewise principal-component analysis in 11C-PIB PET

PET imaging of amyloid deposition in patients with mild cognitive impairment

Forsberg, Anton; Engler, Henry; Almkvist, Ove; Blomquist, Gunnar et al.

Part of Neurobiology of Aging, p. 1456-1465, 2008

DOI for PET imaging of amyloid deposition in patients with mild cognitive impairment

Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine

Darreh-Shori, T.; Kadir, A.; Almkvist, O.; Grut, M. et al.

Part of Neurobiology of Aging, p. 168-184, 2008

DOI for Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine

PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD

Kadir, A.; Darreh-Shori, T.; Almkvist, O.; Wall, Anders et al.

Part of Neurobiology of Aging, p. 1204-1217, 2008

DOI for PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD

A PET study of regional cerebral blood flow after experimental cardiopulmonary resuscitation

Mörtberg, Erik; Cumming, Paul; Wiklund, Lars; Wall, Anders et al.

Part of Resuscitation, p. 98-104, 2007

DOI for A PET study of regional cerebral blood flow after experimental cardiopulmonary resuscitation

Evidence for astrocytosis in ALS demonstrated by 11C(L)-deprenyl-D2 PET

Johansson, Anders; Engler, Henry; Blomquist, Gunnar; Scott, Berit et al.

Part of Journal of the Neurological Sciences, p. 17-22, 2007

DOI for Evidence for astrocytosis in ALS demonstrated by 11C(L)-deprenyl-D2 PET

Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET

Kadir, Ahmadul; Darreh-Shori, Taher; Almkvist, Ove; Wall, Anders et al.

Part of Psychopharmacology, p. 1005-1014, 2007

DOI for Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET

Distribution of zolmitriptan into the CNS in healthy volunteers: a positron emission tomography study

Wall, Anders; Kågedal, Matts; Bergström, Mats; Jacobsson, Eva et al.

Part of Drugs in R&D, p. 139-147, 2005

Publications

Recent publications

All publications

Articles in journal

Conference papers

Datasets

Manuscripts (preprints)